Export 11 results:
Author Title Type [ Year(Desc)]
Filters: Author is Mahalingam, Gokulnath  [Clear All Filters]
2022
Ravi NSam, Wienert B, Wyman SK, Bell HWilliam, George A, Mahalingam G, Vu JT, Prasad K, Bandlamudi BPrasad, Devaraju N, Rajendiran V, Syedbasha N, Pai AAnand, Nakamura Y, Kurita R, Narayanasamy M, Balasubramanian P, Thangavel S, Marepally S, Velayudhan SR et al..  2022.  Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin.. Elife. 11 DOI:10.7554/eLife.65421.
Mahalingam G, Periyasami Y, Arjunan P, Subaschandrabose RKumar, Mathivanan TVenthan, Mathew RSusan, Devi KRamya, Premkumar PSamuel, Muliyil J, Srivastava A, Moorthy M, Marepally S.  2022.  Omicron infection increases IgG binding to spike protein of predecessor variants.. J Med Virol. DOI:10.1002/jmv.28419.
Mahalingam G, Rachamalla HKrishnared, Arjunan P, Periyasami Y, M S, Thangavel S, Mohankumar KM, Moorthy M, Velayudhan SR, Srivastava A, Marepally S.  2022.  Optimization of SARS-CoV-2 Pseudovirion Production in Lentivirus Backbone With a Novel Liposomal System.. Front Pharmacol. 13:840727. DOI:10.3389/fphar.2022.840727.
Rachamalla HKrishnared, Voshavar C, Arjunan P, Mahalingam G, Chowath RPraksash, Banerjee R, Vemula PKumar, Marepally S.  2022.  Skin-Permeable Nano-Lithocholic Lipidoid Efficiently Alleviates Psoriasis-like Chronic Skin Inflammations.. ACS Appl Mater Interfaces. DOI:10.1021/acsami.1c19180.
2023
Mahalingam G, Arjunan P, Periyasami Y, Dhyani AKumar, Devaraju N, Rajendiran V, Christopher ACrystal, Kt RDevi, Dhanasingh I, Thangavel S, Murugesan M, Moorthy M, Srivastava A, Marepally S.  2023.  Correlating the differences in the receptor binding domain of SARS-CoV-2 spike variants on their interactions with human ACE2 receptor.. Sci Rep. 13(1):8743. DOI:10.1038/s41598-023-35070-2.
Rajakumar S, Jamespaulraj S, Shah Y, Kejamurthy P, Jaganathan MK, Mahalingam G, Devi KTRamya.  2023.  Long non-coding RNAs: an overview on miRNA sponging and its co-regulation in lung cancer.. Mol Biol Rep. 50(2):1727-1741. DOI:10.1007/s11033-022-07995-w.
2024
Rajendiran V, Devaraju N, Haddad M, Ravi NSam, Panigrahi L, Paul J, Gopalakrishnan C, Wyman S, Ariudainambi K, Mahalingam G, Periyasami Y, Prasad K, George A, Sukumaran D, Gopinathan S, Pai AAnand, Nakamura Y, Balasubramanian P, Ramalingam R, Thangavel S et al..  2024.  Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expression.. Mol Ther. 32(3):663-677. DOI:10.1016/j.ymthe.2024.01.023.
Mahalingam G, Marepally S.  2024.  In a quest for bivalent mRNA vaccine for respiratory viruses: An effective strategy to overcome antigenic competition.. Mol Ther. 32(4):873-874. DOI:10.1016/j.ymthe.2024.03.011.
Prasad K, Devaraju N, George A, Ravi NSam, Paul J, Mahalingam G, Rajendiran V, Panigrahi L, Venkatesan V, Lakhotiya K, Periyasami Y, Pai AAnand, Nakamura Y, Kurita R, Balasubramanian P, Thangavel S, Velayudhan SR, Newby GA, Marepally S, Srivastava A et al..  2024.  Precise correction of a spectrum of β-thalassemia mutations in coding and non-coding regions by base editors.. Mol Ther Nucleic Acids. 35(2):102205. DOI:10.1016/j.omtn.2024.102205.
Biswas D, Mahalingam G, Subaschandrabose RKumar, Priya S, Ramachandran R, Suresh S, Mathivanan TVenthan, Balu NVijaykumar, Selvaraj K, Nellickal AJose, Christudoss P, Samuel P, Kt RDevi, Marepally S, Moorthy M.  2024.  Role of prior immunity in binding to spike of "future" Omicron subvariants.. Indian J Med Microbiol. 50:100615. DOI:10.1016/j.ijmmb.2024.100615.
Mahalingam G, Rachamalla HKrishnared, Arjunan P, Karuppusamy KV, Periyasami Y, Mohan A, Subramaniyam K, M S, Rajendran V, Moorthy M, Varghese GM, Mohankumar KM, Thangavel S, Srivastava A, Marepally S.  2024.  SMART-lipid nanoparticles enabled mRNA vaccine elicits cross-reactive humoral responses against the omicron sub-variants.. Mol Ther. DOI:10.1016/j.ymthe.2024.02.028.